Genomewide association for schizophrenia in the CATIE study: results of stage 1 - Sullivan, P F; Lin, D; Tzeng, J-Y; van den Oord, E; Perkins, D; Stroup, T S; Wagner, M; Lee, S; Wright, F A; Zou, F; Liu, W; Downing, A M; et al. (Molecular psychiatry, 2008)
Keywords: Adult and adolescent clinical studies; Antipsychotic Agents - therapeutic use; Antipsychotics; Behavioral Sciences; Biological and medical sciences; Biological Psychology; Bipolar disorder; Body mass index; Care and treatment; Case-Control Studies; Collaboration; Computational Biology; Diabetes; Diagnosis; DNA - genetics; DNA - isolation & purification; Epidemiology; Genetic Markers; Genetic Variation; Genetics; Genome, Human; Genomes; Genomics; Genotype; Genotype & phenotype; Genotyping; Humans; Identification and classification; immediate-communication; Management; Medical sciences; Medicine; Medicine & Public Health; Mental disorders; Methods; National Institute of Mental Health (U.S.); Neurosciences; Nucleotide sequence; Pharmacotherapy; Pharmacy; Phenotypes; Polymorphism, Single Nucleotide; Psychiatry; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychoses; Psychotropic drugs; Quality control; Research institutes; Risk factors; Schizophrenia; Schizophrenia - drug therapy; Schizophrenia - genetics; Single-nucleotide polymorphism; United States; United States; United States--US; Indianapolis Indiana; CATIE; genomewide association; schizophrenia; Psychosis; Schizophrenia